Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Founder mutations in BRCA1 and BRCA2 genes.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jun 2007

Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A

Abstract excerpt

BRCA1 and BRCA2 germline mutations contribute to a significant number of familial and hereditary breast and/or ovarian cancers. The proportion of high-risk families with breast and/or ovarian cancer cases due to mutations in these tumor suppressor genes varies widely among populations. In some population, a wide spectrum of different mutations in both genes are present, whereas in other groups specific mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Apoptosis Regulatory Proteins

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Ethnicity

Share to Mutation

Source

Identifiers

PMID: 17591843
DOI: 10.1093/annonc/mdm234

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Founder mutations in BRCA1 and BRCA2 genes.PMID 17591843Read ↗

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Semantic proximity Read ↗

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.Semantic proximity Read ↗

The role of BRCA1/2 in hereditary and familial breast and ovarian cancersSemantic proximity Read ↗

BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in NorwaySemantic proximity Read ↗

BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.Semantic proximity Read ↗

Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.Semantic proximity Read ↗

Discovery of BRCA1/BRCA2 Founder Variants by Haplotype AnalysisSemantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North AfricaSemantic proximity Read ↗

Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.Semantic proximity Read ↗

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.